Skip to main content

Table 2 Multivariable analysis of marker expression and clinical factors with pathologic response

From: p21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer

Variables

p-value

OR (95% CI)

Clinical stage

0.028

0.199 (0.056,0.708)

Pre-operative CEA levels

0.044

0.422 (0.084,2.120)

Ki67

0.999

NA

p21

0.021

0.127 (0.022,0.729)

  1. NA: not applicable :low Ki67 – no pCR observed.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us